Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbay

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 24, 2019
3-Substituted Quinolines as RORγt Inverse AgonistsVirginia M Tanis, Hariharan Venkatesan, Maxwell D Cummings, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2017
Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγtDavid A Kummer, Maxwell D Cummings, Marta Abad, et al.
American Journal of Hematology|January 31, 2017
Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centreMaximilien Grall, Elie Azoulay, Lionel Galicier, et al.
Journal of Thrombosis and Haemostasis : JTH|May 12, 2023
Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest studyJustine Hugon-Rodin, Camille Carrière, Ségolène Claeyssens, et al.
Thrombosis Research|March 31, 2024
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patientsH Lévesque, J F Viallard, E Houivet, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2017
6-Substituted quinolines as RORγt inverse agonistsJ Kent Barbay, Maxwell D Cummings, Marta Abad, et al.
Journal of Medicinal Chemistry|May 26, 2006
Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonistsYong Gong, J Kent Barbay, Alexey B Dyatkin, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase with Oral Anti-Inflammatory ActivityMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Journal of Medicinal Chemistry|January 14, 2012
Design and characterization of optimized adenosine A₂A/A₁ receptor antagonists for the treatment of Parkinson's diseaseBrian C Shook, Stefanie Rassnick, Nathaniel Wallace, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2010
Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonistsBrian C Shook, Stefanie Rassnick, Devraj Chakravarty, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
Bioorganic & Medicinal Chemistry Letters|April 24, 2019
3-Substituted Quinolines as RORγt Inverse AgonistsVirginia M Tanis, Hariharan Venkatesan, Maxwell D Cummings, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2017
Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγtDavid A Kummer, Maxwell D Cummings, Marta Abad, et al.
American Journal of Hematology|January 31, 2017
Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centreMaximilien Grall, Elie Azoulay, Lionel Galicier, et al.
Journal of Thrombosis and Haemostasis : JTH|May 12, 2023
Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest studyJustine Hugon-Rodin, Camille Carrière, Ségolène Claeyssens, et al.
Thrombosis Research|March 31, 2024
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patientsH Lévesque, J F Viallard, E Houivet, et al.
Bioorganic & Medicinal Chemistry Letters|October 29, 2017
6-Substituted quinolines as RORγt inverse agonistsJ Kent Barbay, Maxwell D Cummings, Marta Abad, et al.
Journal of Medicinal Chemistry|May 26, 2006
Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonistsYong Gong, J Kent Barbay, Alexey B Dyatkin, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase with Oral Anti-Inflammatory ActivityMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Journal of Medicinal Chemistry|January 14, 2012
Design and characterization of optimized adenosine A₂A/A₁ receptor antagonists for the treatment of Parkinson's diseaseBrian C Shook, Stefanie Rassnick, Nathaniel Wallace, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2010
Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonistsBrian C Shook, Stefanie Rassnick, Devraj Chakravarty, et al.
Pageof 17